The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin
Clinical trial NCT04601077 · TERMINATED
Trial details
- NCT number
- NCT04601077
- Sponsor
- Nitric Oxide Innovations LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2022-11-30
- Enrollment
- 524
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.